Codiak BioSciences, Inc. Deferred Revenue
Codiak BioSciences, Inc. had Deferred Revenue of $1.36 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2022-11-03
- 2022-09-30: Deferred Revenue, Current $1.36M.
- 2022-06-30: Deferred Revenue, Current $292.00K.
- 2022-03-31: Deferred Revenue, Current $442.00K.
- 2021-12-31: Deferred Revenue, Current $12.96M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2022-09-30 | $1.36M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $292.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $442.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $12.96M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $9.35M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $9.12M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $4.34M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $5.28M 10-K · filed 2022-03-10 |
| 2020-09-30 | $6.27M 10-Q · filed 2020-11-19 |
| 2019-12-31 | $742.00K 10-K · filed 2021-03-17 |